PRELUDE THERAPEUTICS INCORPORATED CONSULTING AGREEMENTPrelude Therapeutics Incorporated Consulting Agreement • April 10th, 2024 • Prelude Therapeutics Inc • Pharmaceutical preparations
This Consulting Agreement (this “Agreement”) is entered into April 8th, 2024 (the “Effective Date”) between Prelude Therapeutics Incorporated, a Delaware corporation with its principal place of business at 175 Innovation Boulevard, Wilmington, Delaware 19805 USA (“Company”) and Laurent Chardonnet (“Consultant”). Company desires to retain Consultant to perform certain consulting activities as described below, and Consultant desires to serve as a consultant to Company and perform such activities under the terms of this Agreement.
SEPARATION AGREEMENT AND GENERAL RELEASESeparation Agreement and General Release • April 10th, 2024 • Prelude Therapeutics Inc • Pharmaceutical preparations • Delaware
This Separation Agreement and General Release (“Agreement”) is between Prelude Therapeutics Incorporated (“Company”) and Laurent Chardonnet (“Employee”).
